August 08. 2022
MDNA Life Sciences Inc S-1

MDNA Life Sciences Inc, which is in the In Vitro & In Vivo Diagnostic Substances [2835] industry, SEC S-1 filing on August 05, 2022 had 61847 (cleaned) words - 600 were utilized for the visualizations.
Top Words:
- 1 - 727 instances
- may - 636 instances
- stock - 631 instances
- common - 453 instances
- company - 447 instances
See the parsed data used in the visualization here.
View the actual filing on the SEC website here